Results 201 to 210 of about 2,196,135 (231)

Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions.

EuroIntervention
BACKGROUND There are limited data about determinant factors of target lesion failure (TLF) in lesions after percutaneous coronary intervention (PCI) using a drug-coated balloon (DCB) for de novo coronary artery lesions, including optical coherence ...
Tetsumin Lee, T. Ashikaga, T. Nozato, Yasutoshi Nagata, Masakazu Kaneko, Ryoichi Miyazaki, T. Misawa, Yuta Taomoto, Shinichiro Okata, M. Nagase, T. Horie, M. Terui, D. Kachi, Y. Odanaka, K. Matsuda, Michihito Naito, Ayaka Koido, T. Yonetsu, T. Sasano   +18 more
semanticscholar   +1 more source

Impact of a Less Than 50% Residual Stenosis Following Vessel Preparation in Femoropopliteal Drug-Coated Balloon Angioplasty

Journal of Endovascular Therapy
Purpose: Drug-coated balloon (DCB) has been established as first-line therapy in femoropopliteal (FP) intervention, and successful vessel preparation (VP) is considered a key element. However, the clinical impact of successful VP remains unknown.
Y. Tomoi, Y. Soga, Kazuaki Imada, Nobuaki Sakai, T. Katsuki, K. Ando   +5 more
semanticscholar   +1 more source

Efficacy and Safety of Optilume Drug-Coated Balloon for Urethral Stricture Treatment: A Systematic Review and Meta-Analysis

Cureus
The Optilume drug-coated balloon (DCB) (North Plymouth, USA) is a novel treatment option for urethral stricture disease that combines mechanical dilation with localized delivery of paclitaxel, an antiproliferative drug aimed at reducing recurrence rates ...
P. Estaphanous, A. O. Khalifa, Y. Makar
semanticscholar   +1 more source

Systematic Review and Network Meta-analysis of Vessel Preparation Techniques With Plain Balloon Angioplasty, Atherectomy, or Intravascular Lithotripsy Before Application of a Drug Coated Balloon to Treat Atherosclerotic Femoropopliteal Disease.

European Journal of Vascular and Endovascular Surgery
OBJECTIVE To compare one year outcomes after atherectomy, intravascular lithotripsy vs. plain balloon angioplasty before application of drug coated balloons for treating femoropopliteal atherosclerotic disease.
J. Yiu, Ravali Tippireddy, L. Biasi, Sanjay Patel, Prakash Saha, A. Saratzis, K. Katsanos, H. Zayed   +7 more
semanticscholar   +1 more source

Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloon.

Future Cardiology
The Magic Touch sirolimus-coated balloon (SCB) was recently introduced in Europe and features robust clinical technology different from other devices on the market.
B. Cortese, S. Malakouti, Jacinthe Khater, Amit Munjal   +3 more
semanticscholar   +1 more source

Comprehensive clinical outcomes of drug‐coated balloon treatment for coronary artery disease. Insights from a single‐center experience

Catheterization and cardiovascular interventions
Some clinical trials have verified the efficacy and safety of paclitaxel drug‐coated balloon (DCB) for small vessel coronary artery disease. However, nonsmall vessel and calcified lesions received less attention.
A. Funatsu, Tatsushi Sato, Jumpei Koike, M. Mizobuchi, Tomoko Kobayashi, Shigeru Nakamura   +5 more
semanticscholar   +1 more source

Comparison of Drug-Coated Balloon to Drug Eluting Stent in Patients with In-Stent Restenosis: A Systematic Review and Meta-Analysis.

American Journal of Cardiology
In-stent restenosis (ISR) is the gradual narrowing of the stented coronary segment, presenting as angina or leading to an acute myocardial infarction. Although the incidence has decreased with the use of newer drug-eluting stents (DES), it still carries ...
Manoj Kumar, Nomesh Kumar, M. Haider, Prakash Upreti, Abdul Rasheed Bahar, Mohammad Hamza, M. Turkmani, S. Basit, Kripa Rajak, Carson Middlebrook, Y. Bahar, Shafaqat Ali, Y. Sattar, M. Alraies   +13 more
semanticscholar   +1 more source

Anterograde placement of drug-coated balloon for ureteroileal anastomosis stricture

BMJ Case Reports
We describe a case of ureteral stricture after radical cystectomy with orthotopic neobladder. The patient presented 4 months after laparoscopic radical cystectomy with intracorporeal orthotopic ileal neobladder, with fever and left lower back pain ...
Luis Rico, Martin Maqueda, Leandro Blas, P. Contreras   +3 more
semanticscholar   +1 more source

One-year Outcomes of Drug-Eluting Stent Versus Drug-Coated Balloon for Femoropopliteal Artery Lesions: BEASTARS Study Results

Journal of Endovascular Therapy
Background: Previous reports have shown comparable outcomes between drug-eluting stents (DESs) and drug-coated balloons (DCBs) for treating femoropopliteal artery (FPA) lesions; however, DCB outcomes include approximately 10% to 50% bailout stents ...
T. Nakama, M. Takahara, Yousuke Iwata, Kenji Suzuki, K. Tobita, Naoki Hayakawa, K. Horie, S. Mori, K. Obunai, Takao Ohki   +9 more
semanticscholar   +1 more source

Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients with Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Current problems in cardiology
BACKGROUND In-stent restenosis (ISR) remains a significant challenge in interventional cardiology despite advancements in stent technology. Drug-coated balloons (DCBs), which deliver antiproliferative agents directly to the vessel wall, have emerged as a
Michael Sabina, J. C. Martínez, A. Khanani, Amanda Rigdon, Philip Owen, Joseph Massaro   +5 more
semanticscholar   +1 more source